September – International Childhood Cancer Awareness Month: New hope for cancer relapse cases

 

Around 2,000 children in Germany are diagnosed with cancer every year. The chances of recovery are now good, but if the cancer comes back, the...

Gene defect influences tumor development in childhood brain tumors

 

Medulloblastoma are the most common malignant brain tumors affecting children. The greatest danger is that the cancer cells can quickly spread to the...

Pan-European registry study shows benefits of cancer genome sequencing for children with cancer

 

In some cases, cancer genome analysis can help find a suitable therapy for children with relapsed cancer and delay the progression of the disease....

New cell culture test to assess drugs against childhood brain tumors

 

Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a test system that measures the...

Coronavirus: Information for families with children with cancer

 

The physicians of the Pediatric Oncology provide information for parents and relatives whose children are receiving or have had cancer treatment....

Award for INFORM clinical trial

 

In many cases, when cancer comes back in children, there are no treatment options left. Through the INFORM study at the Hopp Children’s Cancer Center...

Babies with brain tumors could benefit from targeted treatment

 

Certain brain tumors in infants are biologically different from other childhood brain tumors, and their growth could be inhibited by new targeted...

New concepts for personalized cancer medicine for childhood sarcoma

 

On 1 April, the Hopp Children’s Cancer Center Heidelberg (KiTZ) gained a new research unit dedicated to childhood sarcoma. Called ‘Translational...

Brain tumors in children: Hereditary genetic defect destabilizes protein regulation

 

The causes of 40 percent of all cases of certain medulloblastoma – dangerous brain tumors affecting children – are hereditary. These are the findings...

Ana Banito awarded for her research on soft tissue sarcomas

 

Ana Banito, scientist at the German Cancer Research Center (DKFZ) and the KiTZ received the Award of the Berlin-Brandenburg Academy of Sciences and...